Health & Wellbeing

Canine Herpes Virus in Dogs: Symptoms, Treatment & Prevention Guide

Canine herpes virus in dogs: symptoms, treatment, prevention, and prognosis.

By Robin Maitland · Published 8 September 2026
Canine Herpes Virus in Dogs: Symptoms, Treatment & Prevention Guide

What Is Canine Herpes Virus in Dogs?

Canine herpesvirus-1 (CHV-1) is a highly contagious viral infection that primarily affects dogs and other canids. Unlike human herpes simplex, CHV-1 is species-specific — it cannot be transmitted to humans or cats. The virus targets the reproductive and respiratory tracts, and while adult dogs often experience mild or asymptomatic infections, it is devastatingly lethal to newborn puppies under three weeks of age.

CHV-1 is remarkably common in the global dog population. Seroprevalence studies suggest that 40% to 90% of adult dogs worldwide have been exposed to the virus, according to data compiled in the Merck Veterinary Manual. Most infected adults carry the virus latently for life, meaning it can reactivate during periods of stress, immunosuppression, or pregnancy — often without visible symptoms.

The virus spreads through direct contact with infected nasal, oral, or genital secretions. It is fragile outside the host and does not survive long in the environment, making close-contact transmission (kennels, breeding facilities, dog shows) the primary route. Understanding CHV-1 is essential for any dog owner, but especially for those involved in breeding or who have recently brought home a litter of puppies.

⚠️ Veterinary Disclaimer: This article provides educational information and should not replace professional veterinary care. If you suspect your dog or puppies have been exposed to canine herpes virus, consult your veterinarian immediately. Early intervention is critical, especially for neonates.

Recognizing Canine Herpes Symptoms: A Severity-Based Checklist

CHV-1 presents very differently depending on the dog's age and immune status. The following checklist organizes clinical signs from early warning indicators to advanced, life-threatening symptoms.

Adult Dogs and Older Puppies (Over 3 Weeks)

Severity Symptoms Notes
Mild / Early Mild nasal discharge, occasional sneezing, slight cough, transient lethargy Often mistaken for kennel cough or mild upper respiratory infection; may resolve without treatment
Moderate Persistent cough, conjunctivitis (red/watery eyes), genital lesions or discharge, reduced appetite More common in immunocompromised dogs or during viral reactivation; veterinary evaluation recommended
Advanced Vaginitis or balanoposthitis (genital inflammation), abortion in pregnant females, keratitis (corneal inflammation), pneumonia Requires immediate veterinary attention; reproductive complications can affect entire litters

Newborn Puppies (Under 3 Weeks) — Fading Puppy Syndrome

Severity Symptoms Notes
Early Warning Failure to nurse, weak crying or "paddling" movements, separation from littermates, cool body temperature Onset typically within first 1–2 weeks of life; subtle signs easily missed by inexperienced breeders
Progressive Abdominal pain (crying when handled), yellowish-green nasal discharge, soft yellow-gray feces, hemorrhagic spots on skin (petechiae) Virus is causing systemic organ damage; mortality rate extremely high without intervention
Critical Neurological signs (seizures, incoordination), difficulty breathing, complete cessation of nursing, death within 24–48 hours of symptom onset Mortality in neonates under 3 weeks approaches 80–100% once clinical signs appear

Risk Factors: Which Dogs Are Most Vulnerable?

CHV-1 Risk Factor Profile

  • Age: Puppies under 3 weeks face the highest mortality risk. Their immature immune systems and inability to regulate body temperature make them exceptionally vulnerable. Adult dogs are typically asymptomatic carriers.
  • Breeding environment: Kennels, breeding facilities, and dog shows are high-transmission settings where close contact facilitates viral spread.
  • Immune status: Dogs on immunosuppressive therapy (corticosteroids, chemotherapy) or with concurrent illness (parvovirus, distemper) are at elevated risk for viral reactivation.
  • Pregnancy: Intact females may experience viral reactivation during gestation or whelping stress, potentially infecting puppies in utero or during birth.
  • Breed predisposition: No single breed is genetically predisposed to CHV-1. However, brachycephalic breeds (English Bulldogs, French Bulldogs, Pugs) may experience more severe respiratory complications due to pre-existing airway anatomy. Breeds commonly managed in large breeding operations (Labrador Retrievers, German Shepherds, Golden Retrievers) may see higher exposure rates due to population density.
  • Vaccination status: Unvaccinated breeding females have no circulating antibodies to pass to puppies via colostrum, leaving neonates unprotected during their most vulnerable window.

How Veterinarians Diagnose Canine Herpes Virus

Because CHV-1 symptoms overlap with numerous other canine infections — including canine influenza, Bordetella, and canine distemper — definitive diagnosis requires laboratory testing. Your veterinarian will select tests based on the dog's age, clinical presentation, and whether you are managing a breeding situation.

Diagnostic Process and Tests

  1. Clinical history and physical exam ($50–$120): Your vet will assess symptoms, review breeding history, and evaluate the dog's environment. For neonates, the entire litter and dam will be examined.
  2. PCR testing (polymerase chain reaction) ($80–$200): The gold standard for active infection diagnosis. Swabs are taken from the nasal cavity, conjunctiva, or genital tract. Results typically return in 2–5 business days. PCR detects viral DNA and confirms active shedding.
  3. Serology / antibody titers ($40–$100): Blood tests measuring IgG and IgM antibodies. A rising titer over 2–4 weeks (paired samples) confirms recent infection. Useful for screening breeding stock but less helpful for acute neonatal cases.
  4. Virus isolation ($150–$300): Less commonly used due to longer turnaround (7–14 days) and the fragile nature of CHV-1 in transport. May be performed at specialized veterinary diagnostic laboratories.
  5. Necropsy (post-mortem examination) ($200–$500): In cases of puppy death, necropsy with histopathology can confirm CHV-1 by identifying characteristic intranuclear inclusion bodies in liver, lung, and kidney tissue. This is critical for protecting surviving littermates.
  6. Complete blood count (CBC) and chemistry panel ($80–$180): Not diagnostic for CHV-1 specifically but reveals secondary complications — thrombocytopenia (low platelets), elevated liver enzymes, and leukopenia (low white blood cells) are common findings in affected neonates.
Total diagnostic cost estimate: For an adult dog, expect $200–$500 for a comprehensive workup. For a litter of puppies with suspected CHV-1, diagnostic costs may range from $400–$1,200 depending on how many puppies are tested and whether necropsy is performed.

Treatment Options for Canine Herpes Virus

There is no cure for CHV-1 once a dog is infected — the virus establishes lifelong latency. Treatment focuses on supportive care, managing clinical symptoms, and preventing secondary bacterial infections. The approach differs dramatically between adult dogs and neonatal puppies.

Treatment Category Adult Dogs Neonatal Puppies Success Rate
Antiviral therapy Acyclovir or valacyclovir may be prescribed off-label for severe outbreaks; dosage determined by veterinarian (typically 10–20 mg/kg every 8 hours) Rarely effective once clinical signs appear; some breeders and vets use acyclovir prophylactically in exposed but asymptomatic littermates Limited data; may reduce viral shedding in adults
Antibiotics (secondary infection control) Broad-spectrum antibiotics (amoxicillin-clavulanate, doxycycline) to prevent bacterial pneumonia or secondary infections Injectable antibiotics (e.g., amikacin, ceftiofur) administered by veterinary guidance Effective for secondary infections; does not treat the virus itself
Supportive care Fluid therapy, nutritional support, rest, isolation from other dogs Supplemental warmth (incubator at 85–90°F / 29–32°C), tube or bottle feeding, subcutaneous fluids, oxygen therapy Adults: high recovery rate. Neonates: poor prognosis once symptomatic
Immune support Immune-modulating supplements (omega-3 fatty acids, probiotics) may support general immune function Hyperimmune serum from recovered dogs has been used experimentally; availability is limited Anecdotal; limited peer-reviewed evidence

Prognosis and Life Expectancy by Disease Stage

The prognosis for CHV-1 varies enormously depending on the dog's age at infection and the timeliness of intervention.

Patient Category Prognosis Expected Outcome
Adult dogs (asymptomatic carriers) Excellent Normal life expectancy. The virus remains latent and rarely causes clinical disease. Periodic reactivation may cause brief, mild respiratory signs that resolve without treatment.
Adult dogs (symptomatic) Good to fair Most recover fully within 1–3 weeks with supportive care. Reproductive complications (infertility, abortion) may be permanent. Genital lesions typically resolve but can recur.
Puppies 3+ weeks old Fair to good Developing immune systems can often fight the infection. With aggressive supportive care, survival is possible. Some puppies may have lasting organ damage (liver, kidneys).
Puppies under 3 weeks Poor to grave Mortality rate is estimated at 80–100% once clinical signs develop. Death typically occurs within 24–48 hours. Survival is rare even with intensive veterinary intervention. Source: Merck Veterinary Manual.

Home Care and Daily Management

For adult dogs recovering from a CHV-1 flare-up, home management focuses on comfort, isolation, and monitoring. For breeders managing a potentially exposed litter, intensive around-the-clock care is required.

Adult Dog Home Care Protocol

  • Isolation: Separate the infected dog from all other dogs for a minimum of 3 weeks. CHV-1 is shed in nasal and genital secretions during active infection.
  • Environmental hygiene: CHV-1 is easily destroyed by common disinfectants. Clean all bowls, bedding, and surfaces with a 1:32 dilution of household bleach (approximately ½ cup bleach per gallon of water). The virus does not survive more than a few hours outside the host at room temperature.
  • Nutrition: Offer highly palatable, easily digestible food. Warm canned food or add low-sodium chicken broth to kibble to encourage eating if appetite is reduced.
  • Monitoring: Track temperature daily (normal: 101–102.5°F / 38.3–39.2°C). Contact your veterinarian if fever exceeds 103.5°F (39.7°C) for more than 24 hours, or if respiratory symptoms worsen.
  • Stress reduction: Minimize environmental stressors (loud noises, schedule changes, new animals) to reduce the likelihood of viral reactivation in known carriers.

Neonatal Puppy Management (Breeder Protocol)

  • Thermal support: Maintain ambient temperature at 85–90°F (29–32°C) for the first week, gradually reducing to 75°F (24°C) by week four. Use a veterinary incubator or a heating pad set on low under half the whelping box (so puppies can move away from heat).
  • Assisted feeding: If puppies are too weak to nurse, use a commercial canine milk replacer (e.g., Esbilac or Royal Canin Babydog Milk) via esophageal tube feeding every 2–3 hours. Consult your veterinarian for proper tube-feeding technique and volume calculations (approximately 1 mL per ounce of body weight per feeding for neonates).
  • Litter separation: If one puppy shows symptoms, immediately isolate it from healthy littermates. Have your veterinarian evaluate the entire litter and the dam.
  • Record keeping: Document weight gains daily. A healthy neonate should gain 5–10% of its birth weight per day. Weight loss or failure to gain is an early warning sign.

Treatment Cost Breakdown: What to Budget

The financial impact of CHV-1 depends heavily on whether you are treating a single adult dog or managing an affected litter. Below are realistic 2026 cost ranges based on typical U.S. veterinary pricing.

Scenario Low Estimate High Estimate What's Included
Adult dog — mild case $150 $400 Exam, PCR test, antibiotics, follow-up visit
Adult dog — severe/reproductive $500 $2,000 Full diagnostics, antiviral therapy, reproductive evaluation, possible pregnancy management
Neonatal litter (per puppy, supportive) $300 $1,500 Incubation, tube feeding, injectable medications, daily monitoring
Neonatal litter (emergency/ICU) $1,000 $5,000+ 24-hour hospitalization, oxygen therapy, IV fluids, emergency veterinary care
Necropsy (per puppy) $200 $500 Full post-mortem with histopathology and viral identification
Prevention (vaccination per dam) $60 $120 Eurican Herpes 205 or equivalent (availability varies by region); two doses per breeding cycle

For breeders, the worst-case financial scenario involves an entire litter lost to CHV-1 plus diagnostic and necropsy costs — potentially $2,000–$8,000 in combined veterinary expenses, not including the lost value of the puppies. Pet insurance typically covers diagnostic and treatment costs for CHV-1 if the policy was active before the infection, but pre-existing condition exclusions apply.

Prevention Strategies: Protecting Your Dog and Future Litters

Prevention is far more effective than treatment when it comes to CHV-1, particularly in breeding scenarios.

Vaccination

A CHV-1 vaccine (Eurican Herpes 205, manufactured by Boehringer Ingelheim) is available in many European countries and some other regions. As of 2026, no CHV-1 vaccine is currently licensed in the United States, though some veterinarians may be able to access it through USDA import permits for high-risk breeding operations. The vaccine protocol involves two injections: one at estrus (heat) or early pregnancy, and a second 1–2 weeks before whelping. This boosts maternal antibodies passed to puppies through colostrum, providing critical protection during their first three weeks.

Biosecurity Measures

  • Pre-breeding screening: Test both the dam and sire for CHV-1 antibodies before breeding. Seropositive dogs are carriers and may shed the virus during stress.
  • Isolation of new dogs: Quarantine any new dog entering a breeding facility or multi-dog household for 2–3 weeks. Perform serological testing before introducing them to the group.
  • Whelping hygiene: Wash hands thoroughly before handling newborns. Limit visitors during the first three weeks of a litter's life. Require shoe covers or foot baths at kennel entrances.
  • Stress management: Avoid transporting pregnant females during late gestation. Minimize environmental changes, loud events, and introductions to new animals during the peripartum period.
  • Cesarean section consideration: In high-risk situations (known CHV-positive dam), some veterinary reproduction specialists recommend planned C-sections to reduce neonatal exposure during passage through the birth canal, followed by hand-rearing with colostrum from a CHV-negative foster dam or commercial colostrum supplement.
Key Prevention Takeaway: The most effective strategy for protecting puppies is ensuring the dam has high circulating antibody levels at whelping — either through vaccination (where available) or through natural exposure well before breeding. Colostrum intake within the first 8–12 hours of life is non-negotiable for passive immunity transfer.

When to See the Vet: Red Flag Symptoms

🚨 Seek Immediate Veterinary Care If You Observe:

  • Newborn puppies: Any puppy under 3 weeks that stops nursing, becomes cold to the touch, cries persistently, or separates from the litter — this is a medical emergency. Mortality can occur within 24 hours.
  • Pregnant females: Unexplained vaginal discharge, abortion, stillbirths, or any sign of illness during late gestation.
  • Adult dogs: High fever (>103.5°F / 39.7°C) lasting more than 48 hours, difficulty breathing, severe lethargy, or neurological symptoms (seizures, disorientation, head tilt).
  • Multi-dog households: If one dog is diagnosed with CHV-1, all dogs in the household should be evaluated by a veterinarian, even if asymptomatic.
  • Genital lesions: Any unexplained genital sores, discharge, or inflammation in intact dogs — particularly before planned breeding.

Emergency contacts:

  • Your primary veterinarian or nearest emergency veterinary hospital
  • ASPCA Animal Poison Control: (888) 426-4435 (24/7, consultation fee applies) — for questions about medication safety during treatment

Frequently Asked Questions About Canine Herpes Virus

Can humans catch canine herpes from their dogs?

No. CHV-1 is species-specific and cannot infect humans, cats, or other non-canid species. You can safely handle an infected dog without risk of contracting the virus. However, practice good hygiene (hand washing) to avoid mechanically transferring the virus to other dogs via your hands or clothing.

Is canine herpes the same as kennel cough?

No. While CHV-1 can cause mild respiratory symptoms that resemble kennel cough (which is typically caused by Bordetella bronchiseptica and/or canine parainfluenza virus), they are entirely different pathogens. CHV-1 is a herpesvirus, while kennel cough is primarily bacterial or caused by different viral agents. Your veterinarian can differentiate these through PCR testing.

Can a dog with canine herpes still be bred?

This is a complex decision that should be made with your veterinarian and a veterinary reproduction specialist. Seropositive dogs are lifelong carriers and may shed the virus during breeding stress. If both the dam and sire are seropositive, breeding may proceed with careful management (vaccination where available, stress reduction, neonatal monitoring). Breeding a known-positive dog to a negative dog risks transmitting the virus. Full transparency with all breeding partners is essential.

How long does the canine herpes virus survive on surfaces?

CHV-1 is an enveloped virus, making it fragile outside the host. It typically survives only a few hours at room temperature on dry surfaces. It is readily inactivated by most common disinfectants including bleach (1:32 dilution), quaternary ammonium compounds, and 70% isopropyl alcohol. This is one advantage of CHV-1 compared to hardier viruses like parvovirus, which can persist in the environment for months.

What is the life expectancy of a dog that survives canine herpes?

Adult dogs that experience a CHV-1 infection typically have a normal life expectancy. The virus remains latent in nerve tissue (trigeminal ganglia) and may reactivate periodically, but recurrent episodes in immunocompetent adults are usually mild or subclinical. Puppies that survive neonatal infection (rare but possible, especially if infected after 2–3 weeks of age) may have permanent organ damage, particularly to the liver and kidneys, which could shorten lifespan depending on severity. A veterinary internal medicine specialist can assess long-term prognosis through blood chemistry and imaging.

Should I test my dog for canine herpes before breeding?

Yes. Pre-breeding CHV-1 serology is considered a best practice by veterinary reproduction specialists, particularly for dogs in kennels, those with unknown histories, or dogs being shipped for breeding. Testing allows you to make informed decisions about mating pairs and implement protective protocols. Consult your veterinarian about CHV-1 screening as part of a comprehensive pre-breeding health panel that should also include brucellosis testing, hip/elbow evaluation, and breed-specific genetic screening.

Sources consulted: Merck Veterinary Manual — Canine Herpesvirus Infection, American Kennel Club — Canine Herpesvirus, and peer-reviewed literature from the Journal of Veterinary Internal Medicine.

Written by

Robin Maitland

All our authors care for dogs every day — read more of their work on the authors page.